Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanoma
在BRAF突变转移性黑色素瘤患者中,抗PD-1单药治疗或联合伊匹木单抗治疗在BRAF/MEK抑制剂治疗后的疗效和安全性
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-004610
Pires da Silva, Ines; Zakria, Danny; Ahmed, Tasnia; Trojanello, Claudia; Dimitriou, Florentia; Allayous, Clara; Gerard, Camille; Zimmer, Lisa; Lo, Serigne; Michielin, Olivier; Lebbe, Celeste; Mangana, Johanna; Ascierto, Paolo Antonio; Johnson, Douglas B; Carlino, Matteo; Menzies, Alexander; Long, Georgina